VEGFA and neoplasm: US28 regulates the VEGF promoter activity via the Gαq, Gβγ, p38, and p44/42 kinases and induces VEGF gene upregulation, which is one of the major factors for tumor progression in GBM patients (Maussang et al., 2006; Maussang et al., 2009).